Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

Published:2015-01-03 Issue:6 Volume:62 Page:1078-1080
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Gossai Nathan¹,Hilgers Megan V.²,Polgreen Lynda E.³,Greengard Emily G.¹

Affiliation:

1. Department of Pediatrics; Division of Pediatric Hematology and Oncology; University of Minnesota Children's Hospital; Minneapolis Minnesota

2. Department of Pediatrics; University of Minnesota Children's Hospital; Minneapolis Minnesota

3. Department of Pediatrics; Division of Endocrinology; Los Angeles Biomedical Research Institute at Harbor-UCLA; Torrance California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference14 articles.

1. Giant cell tumor of bone;Thomas;Curr Opin Oncol,2009

2. A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases;Miller;Diagn Pathol,2010

3. Denosumab in patients with giant cell tumour of bone: An open-label, phase 2 study;Thomas;Lancet Oncol,2010

4. Golden bullet-denosumab: Early rapid response of metastatic giant cell tumor of the bone;Demirsoy;J Pediatr Hematol Oncol,2014

5. Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab;Hakozaki;Diagn Pathol,2014

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypercalcemia in children induced by denosumab: a case report and an analysis of the FDA adverse event reporting system database;Expert Opinion on Drug Safety;2024-07-15

2. Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document;The Journal of Clinical Endocrinology & Metabolism;2023-12-02

3. Hypercalcemia in Children Following a Discontinuation of Denosumab Therapy: A Case Report and Literature Review;Clinical Pediatrics;2023-08-18

4. Diagnosis and monitoring denosumab therapy of giant cell tumors of bone: radiologic-pathologic correlation;Skeletal Radiology;2023-07-29

5. Denosumab Treatment Does Not Halt Progression of Bone Lesions in Multicentric Carpotarsal Osteolysis Syndrome;JBMR Plus;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3